Downregulation of ANXA3 was also reported in papillary thyroid cancer (PTC), and PTC patients with decreased ANXA3 expression exhibited substantially elevated lymph node metastasis scores and tumor growth (Jung et al., 2010). The gene discussed is ANXA3; the disease is thyroid gland papillary carcinoma.